argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
01 feb 2021 - 07:00
Statutory name
argenx SE
Title
argenx Announces “GO” Decision in ADHERE Trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy Following Interim Analysis
Date last update: 23 June 2026